GREAT NEWS...THANKS DR. REID...
Diagnos signs MOU with U.S. hospital for Cardio
2019-03-27 10:08 ET - News Release
Dr. Reid Maclellan reports
DIAGNOS ANNOUNCES MEMORANDUM OF UNDERSTANDING WITH ONE OF THE 5 LARGEST HOSPITALS IN THE US FOR THE FINAL DEVELOPMENT OF ITS CARDIO APPLICATION
Diagnos Inc. has signed a memorandum of understanding to establish a framework between one hospital in the United States and Diagnos.
Under the terms of a mutual non-disclosure agreement, the name of the hospital can't be disclosed. The hospital is engaged and specializes in the medical field of stroke and related cardiological issues. The hospital has one of the largest databases in the world for stroke related patients. Diagnos will utilize this database to finalize the development and validation for Cardio.
Cardio is an application that predicts the future risk of a patient having a stroke or other conditions that may lead to a stroke. "We are honored to form this relationship with a hospital and team of clinicians that are truly experts in the field of stroke. Using our FL AI RE platform we are able to analyse the retina and derive the key features that predict a stroke. Having access to the thousands of medical records from our hospital partner will enable Diagnos to finish the development and testing of the application. The screening will be done with the same commercial fund us camera used for identifying retinopathy with diabetic patients," commented Dr. Reid Maclellan, director at Diagnos.
The Corporation is also announcing that a new date of April 10th, 2019 has been fixed for the meeting of the Debentureholders initially scheduled for April 4th, 2019 as stated in the Corporate Reorganization press release of March 11th, 2019. The decision of rescheduling the meeting date to April 10th, 2019 was undertaken to allow the Corporation to efficiently comply with the mailing of meeting material requirements.
About Diagnos